These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9846474)

  • 1. [Treatment of pancreatogenic digestive disorders. Tolerance and effectiveness of a modern pancreatic enzyme substitute].
    Hedding-Eckerich M; Eckert MW
    Fortschr Med; 1998 Oct; 116(29):48-9. PubMed ID: 9846474
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea].
    Kölbel C; Layer P; Hotz J; Goebell H
    Med Klin (Munich); 1986 Feb; 81(3):85-6. PubMed ID: 3641037
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of panzytrat--modern physiological enzyme preparation in complex therapy of pancreatic exocrine secretory insufficiency in cholelithiasis].
    Petukhov VA; Mironov AV; Semenov ZhS; Ustinov FS
    Eksp Klin Gastroenterol; 2009; (1):72-80. PubMed ID: 19551960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
    Farkas G; Leindler L; Mihalovits G
    Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid.
    Fric P; Malis F; Kasafírek E; Slabý J
    Hepatogastroenterology; 1980 Jun; 27(3):220-3. PubMed ID: 6970159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of Panzytrat in the replacement therapy of exocrine pancreatic insufficiency (an analytical review)].
    Karamysheva EI; Lobanova EG
    Eksp Klin Gastroenterol; 2002; (4):47-50, 132. PubMed ID: 12503276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreatic enzyme preparations].
    Lamers CB
    Ned Tijdschr Geneeskd; 1987 Oct; 131(40):1750-2. PubMed ID: 3670478
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
    Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
    Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC
    Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
    [No Abstract]   [Full Text] [Related]  

  • 14. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substitution therapy in insufficient external pancreatic secretion].
    Simek I; Duda M; Kubias K
    Vnitr Lek; 1993 Mar; 39(3):250-2. PubMed ID: 8506676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine exocrine pancreatic insufficiency treated with porcine pancreatic extract.
    Kim JW; Jung DI; Kang BT; Kim HJ; Park C; Park EH; Lim CY; Park HM
    J Vet Sci; 2005 Sep; 6(3):263-6. PubMed ID: 16131834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution of digestive enzymes in elderly patients].
    Jansen W
    Med Welt; 1982 Sep; 33(37):1281-2. PubMed ID: 6182442
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to: properties of different pancreatin preparations used in pancreatic exocrine insufficiency, Löhr JM et al. Eur J Gastroenterol Hepatol 2009; 21(9):1024-1031.
    Lederer PC
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635; author reply 636-7. PubMed ID: 20393299
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Piehl S; Brinkmann R; Windeck T
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):635-6; author reply 636-7. PubMed ID: 20393298
    [No Abstract]   [Full Text] [Related]  

  • 20. Indication for pancreatic enzyme treatment in non-pancreatic digestive diseases.
    Gullo L
    Digestion; 1993; 54 Suppl 2():43-7. PubMed ID: 8224571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.